These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22126240)

  • 1. Are 'omics of estrogen receptors defining potential targets for breast cancer treatment?
    Métivier R
    Epigenomics; 2011 Oct; 3(5):525-8. PubMed ID: 22126240
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic analysis in the search for tumor suppressor genes.
    Han ZG
    Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
    [No Abstract]   [Full Text] [Related]  

  • 3. Largest ever DNA methylation dataset for breast cancer completed.
    Dedeurwaerder S; Desmedt C; Calonne E
    Expert Rev Mol Diagn; 2011 Jun; 11(5):470. PubMed ID: 21842555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
    Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN
    Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.
    Björkman M; Rantala J; Nees M; Kallioniemi O
    Epigenomics; 2010 Oct; 2(5):683-9. PubMed ID: 22122051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
    Knower KC; To SQ; Simpson ER; Clyne CD
    Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.
    Yamamoto M; Ito T; Shimizu T; Ishida T; Semba K; Watanabe S; Yamaguchi N; Inoue J
    Cancer Sci; 2010 Nov; 101(11):2391-7. PubMed ID: 20735436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and chromatin structure: the puzzling CpG islands.
    Caiafa P; Zampieri M
    J Cell Biochem; 2005 Feb; 94(2):257-65. PubMed ID: 15546139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal gene regulation through DNA methylation and demethylation.
    Kouzmenko A; Ohtake F; Fujiki R; Kato S
    Epigenomics; 2010 Dec; 2(6):765-74. PubMed ID: 22122081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
    Li SY; Rong M; Iacopetta B
    Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
    Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
    Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of epigenetics in mental disorders.
    Stuffrein-Roberts S; Joyce PR; Kennedy MA
    Aust N Z J Psychiatry; 2008 Feb; 42(2):97-107. PubMed ID: 18197504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues.
    Izawa M; Taniguchi F; Uegaki T; Takai E; Iwabe T; Terakawa N; Harada T
    Fertil Steril; 2011 Jan; 95(1):33-9. PubMed ID: 20655525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
    van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
    Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of genetic and epigenetic alterations in cancer.
    Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
    Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
    Martens JW; Nimmrich I; Koenig T; Look MP; Harbeck N; Model F; Kluth A; Bolt-de Vries J; Sieuwerts AM; Portengen H; Meijer-Van Gelder ME; Piepenbrock C; Olek A; Höfler H; Kiechle M; Klijn JG; Schmitt M; Maier S; Foekens JA
    Cancer Res; 2005 May; 65(10):4101-17. PubMed ID: 15899800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.